
🧬 Biotech Investing Unlocked: Mindset Shift, Risk, and Founder-First Lessons | Johnny Hu (Part 3/4)
06/02/25 • 37 min
- Navigating the transition from scientist to venture capitalist: Adapting to new mindsets
- The importance of operational discipline, capital efficiency, and decision-making in biotech startups: Stretching every dollar
- Lessons learned from mentors and experiences at Omega Funds: Start with the end in mind
- The value of founder-first investing and building intentional, transparent relationships with entrepreneurs: Build trust and clarity
- The impact of AI and technological innovation on biotech, and the unique challenges of risk assessment in life sciences: Managing risk in complex systems
- Navigating the transition from scientist to venture capitalist: Adapting to new mindsets
- The importance of operational discipline, capital efficiency, and decision-making in biotech startups: Stretching every dollar
- Lessons learned from mentors and experiences at Omega Funds: Start with the end in mind
- The value of founder-first investing and building intentional, transparent relationships with entrepreneurs: Build trust and clarity
- The impact of AI and technological innovation on biotech, and the unique challenges of risk assessment in life sciences: Managing risk in complex systems
Previous Episode

🧬 The Shelf Life of Innovation: CRISPR, Biotech Culture & Winning Teams | Johnny Hu (Part 2/4)
🧬 The Biotech Startups Podcast is powered by Excedr —helping life science startups accelerate R&D and commercialization with founder-friendly equipment leasing. Skip the upfront costs, stay lean, and focus on breakthrough science.As a TBSP listener, you can get exclusive perks through Excedr’s partner network—special savings, promotions, and more. Explore these offers today: https://www.excedr.com/partners."Every technology has a shelf life. It’s just true, right? And, so, is that shelf life years? Is it months? Is it weeks? Is it days? You know, has it actually already been surpassed? That’s just progress, right? That’s great”In this episode, Johnny Hu, Principal at Menlo Ventures, unpacks his journey through neuroscience research at Genentech and Cambridge, the electrifying early days of CRISPR, and the fast-moving Boston biotech scene, revealing how academic culture, tool-building, and intentional company culture fuel breakthrough innovation. He offers a candid look at bridging academia and industry, the realities of risk and execution in biotech startups, and the collaborative and competitive dynamics of venture investing—showing what it really takes to thrive where science, startups, and investment meet.Key topics covered:
- The Value of Academic Culture: Cambridge’s traditions and cross-disciplinary thinking fueled Johnny’s passion for building tools and deep scientific exploration.
- The Rise of CRISPR: Inside the early, high-energy days of gene editing’s rapid ascent.
- Boston Biotech Ecosystem: How a dense, connected community unlocked opportunities in startups and venture capital.
- Company Culture & Team Dynamics: Why setting culture early shapes how teams execute and succeed.
- Investing in Biotech: The real work of weighing risk, building strong boards, and making tough calls in venture.
Next Episode

🧬 AI, Mentors & the Future of Biotech: Teambuilding, Investing, & Innovation | Johnny Hu (Part 4/4)
🧬 The Biotech Startups Podcast is powered by Excedr —helping life science startups accelerate R&D and commercialization with founder-friendly equipment leasing. Skip the upfront costs, stay lean, and focus on breakthrough science.As a TBSP listener, you can get exclusive perks through Excedr’s partner network—special savings, promotions, and more. Explore these offers today: https://www.excedr.com/partners.“It's the partnership all the way down, and everyone needs to be around the table to enable the ecosystem.”In this episode of The Biotech Startups Podcast, Johnny Hu reflects on his path to becoming a Principle at Menlo Ventures, what it's been like returning to gene editing after years away, and how he's thinking about unlocking true platform potential in life sciences. He also shares his outlook on early-stage biotech, the importance of mentorship, intellectual range and curiosity, and what's ahead as he continues building at the intersection of biology, computation, and company creationKey topics covered:
- Firm building: Building a venture firm from the ground up
- AI & Bio: Looking at the intersection of AI and Biology
- Gene Editing: The clinical success of gene editing
- Mentorship: The importance of mentors and advisors
- Career Advice: Tips and common pitfalls to avoid when starting a career in venture investing
If you like this episode you’ll love
Episode Comments
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/the-biotech-startups-podcast-273960/biotech-investing-unlocked-mindset-shift-risk-and-founder-first-lesso-92883941"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to 🧬 biotech investing unlocked: mindset shift, risk, and founder-first lessons | johnny hu (part 3/4) on goodpods" style="width: 225px" /> </a>
Copy